OWC Pharmaceutical Research Corp (OWCP)
0.00
USD |
OTCM |
Apr 25, 16:00
OWC Pharmaceutical Research Free Cash Flow (Quarterly)
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2019 | -0.372M |
| June 30, 2019 | -0.957M |
| March 31, 2019 | -0.665M |
| December 31, 2018 | -0.756M |
| September 30, 2018 | -0.43M |
| June 30, 2018 | -0.96M |
| March 31, 2018 | -0.381M |
| December 31, 2017 | -0.6065M |
| September 30, 2017 | 0.0016M |
| June 30, 2017 | -0.3925M |
| March 31, 2017 | -0.1987M |
| December 31, 2016 | -0.143M |
| September 30, 2016 | -0.122M |
| June 30, 2016 | -0.1041M |
| March 31, 2016 | -0.162M |
| December 31, 2015 | -0.172M |
| September 30, 2015 | -0.2924M |
| June 30, 2015 | -0.3656M |
| March 31, 2015 | -0.3887M |
| Date | Value |
|---|---|
| December 31, 2014 | -0.2795M |
| September 30, 2014 | -0.3159M |
| June 30, 2014 | -0.0225M |
| March 31, 2014 | -0.0167M |
| December 31, 2013 | -0.0091M |
| September 30, 2013 | -0.0137M |
| June 30, 2013 | -0.0495M |
| March 31, 2013 | -0.0195M |
| December 31, 2012 | -0.0024M |
| September 30, 2012 | 0.0095M |
| June 30, 2012 | -0.0028M |
| March 31, 2012 | -0.0459M |
| September 30, 2009 | -0.0412M |
| June 30, 2009 | -0.0828M |
| March 31, 2009 | -0.0717M |
| December 31, 2008 | -0.0751M |
| September 30, 2008 | -0.0035M |
| June 30, 2008 | -0.0301M |
| March 31, 2008 | 0.00 |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-0.957M
Minimum
Jun 2019
-0.372M
Maximum
Sep 2019
-0.6645M
Average
-0.6645M
Median
Free Cash Flow (Quarterly) Benchmarks
| Taro Pharmaceutical Industries Ltd | -3.553M |
| InspireMD Inc | -4.392M |
| Ayala Pharmaceuticals Inc | -- |
| BiomX Inc | -6.249M |
| Alpha Tau Medical Ltd | -- |